Importantly, we do not, however, observe drug induced accelerated tumor growth in vivo in contrast to observations created with

GDC 0879. 1t can be very well tolerated, without any adverse results observed following every day drug treatment method for prolonged intervals, and we also didn't observe any skin lesions of your variety described with a different BRAF inhibitor, GDC 0879. This also demonstrates that off target activity against kinases for instance SRC, LCK or p38 inhibition was not inherently toxic.